Synthesis, crystal structure and anti-malarial activity of novel spiro- 1,2,4,5-tetraoxacycloalkanes

Tetrahedron Letters

Volumn 40, Issue 21, 1999, Pages 4077-4080

  Tsuchiya, Kaoru ^a   Hamada, Yoshiaki ^a   Masuyama, Araki ^a   Nojima, Masatomo ^a   McCullough, Kevin J ^b   Kim, Hye Sook ^c   Shibata, Yasuharu ^c   Wataya, Yusuke ^c  

^a OSAKA UNIVERSITY   (Japan)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CYCLOALKANE DERIVATIVE; SPIRO 1,2,4,5 TETRAOXACYCLOALKANE; UNCLASSIFIED DRUG;

ALKYLATION; ANTIMALARIAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PLASMODIUM FALCIPARUM; X RAY CRYSTALLOGRAPHY;

PLASMODIUM FALCIPARUM;

EID: 0033591173     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)00653-X     Document Type: Article

References (26)

1. (1) (a) Casteel, D. A. Natural Product Reports, 1992, 289;
2. (b) Posner, G. H.; Tao, X.; Cumming, J. N.; Klinedinst, D.; Shapiro, T. A. Tetrahedron Lett. 1996, 37, 7225.
3. (c) Zhou, W. -S. Xu, X. -X. Acc. Chem. Res., 1994, 27, 211.
4. (d) Haynes, R. K.; Vonwiller, S. C. Acc. Chem. Res. 1997, 30, 73.
5. (c) Dussault, P. H.; Woller, K. J. Am. Chem. Soc. 1997, 119, 3824.
6. (e) Robert, A.; Meunier, B. Chem. Soc. Rev., 1998, 27, 273.
7. (f) O'Neill, P. M.; Searle. N. L.; Raynes, K. J.; Maggs, J. L.; Ward, S. A.; Storr, R. C.; Park, B. K.; Posner, G. H. Tetrahedron Lett. 1998. 39, 6065.
8. (g) Bachi, M. D.; Korshin, E. E. Synlett. 1998, 122.
9. (h) Posner, G. H.; O'Dowd, H.; Caferro, T.; Cumming, J. N.; Ploypradith, P.; Xie, S.; Shapiro, T. A. Tetrahedron Lett. 1998, 39, 2273.
10. (i) Mekonnen, B.; Ziffer, H. Tetrahedron Lett. 1997, 38, 731.
11. (j) Nowak, D. M.; Lansbury, P. T. Tetrahedron 1998, 54, 319.
12. (2) (a) McCullough, K.J.; Morgan, A.R.; Nonhebel, D.C.; Pauson, P.L.; White, G.J. J. Chem. Res. (S), 1980, 34; (M), 0601.
13. (b) Shulz, M.; Kirschke, K in "Organic Peroxides" Vol 3 (ed. Swern, D.), Wiley, New York, 1972, pp.67-140.
14. (3) Vennerstrom, J. L.; Fu, H.-N.; Ellis, W. Y.; Ager, A. L. Jr.; Wood, J. K.; Andersen, S. L.; Gerena, L.; Milhous, W. K. J. Med. Chem. 1992, 35, 3023, and the references therein.
15. (4) (a) Dussault, P. H.; Sahli, A.; Westermeyer, T. J. Org. Chem. 1993, 58, 5469.
16. (b) Allen, J. L.; Paquette, K. P.; Porter, N. A. J. Am. Chem. Soc. 1998, 120, 9362.
17. (5) Saito, I.; Nagata, R.; Yuba, K.; Matsuura, T. Tetrahedron Lett., 1983, 24, 1737.
18. (6) The preparation of bishydroperoxides by the ozonolysis of an alkene in the presence of hydrogen peroxide has been reported once previously: Robertson, J. C.; Verzine, W. J. J. Org. Chem. 1970, 35, 545.
19. 4. After evaporation of the solvent under reduced pressure, bishydroperoxide 3a (232 mg, 33%) was isolated from the resulting residue by column chromatography [silica gel, eluting with ether-hexane (1:10) followed by with ether-hexane (3:7)].
20. (8) Ledaal, T.; Sorbjoer, T. Acta Chem. Scand. 1967, 21, 1658. See also, Jefford, C. W.; Li, Y.; Jaber, A.; Boukouvalas, J. Synth. Commun. 1990, 20, 2589.
21. (9) Because bishydroperoxides 3 are potentially hazardous compounds, they must be handled with due care. No particular difficulties have been experienced in the isolation of the bishydroperoxides 3 and in the preparation of the new peroxides 4 using the reaction scales and procedures described.
22. 4: C, 67.10; H, 10.56. Found: C, 66.66; H, 10.49.
23. 2 = 0.104.
24. (12) Groth, P. Acta Chem. Scand. Sect. A, 1975, 29, 840.
25. (13) Kim, H.-S., Miyake, H., Arai, M.; Wataya, Y. Parasitol. Int., 1998, 47, 59.
26. (14) SHELXTL/PC (Vers 5.03), Sheldrick, G.M. Siemens Analytical X-ray Instruments Inc., Madison, WI, USA.